Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells.

Abstract

In this study we have quantitatively assessed the basal turnover of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and M3-muscarinic receptor-mediated changes in phosphoinositides in the human neuroblastoma cell line, SH-SY5Y. We demonstrate that the polyphosphoinositides represent a minor fraction of the total cellular phosphoinositide pool and that in addition to rapid, sustained increases in [3H]inositol phosphates dependent upon the extent of receptor activation by carbachol, there are equally rapid and sustained reductions in the levels of polyphosphoinositides. Compared with phosphatidylinositol 4-phosphate (PtdIns(4)P), PtdIns(4,5)P2 was reduced with less potency by carbachol and recovered faster following agonist removal suggesting protection of PtdIns(4,5)P2 at the expense of PtdIns(4)P and indicating specific regulatory mechanism(s). This does not involve a pertussis toxin-sensitive G-protein regulation of PtdIns(4)P 5-kinase. Using wortmannin to inhibit PtdIns 4-kinase activity, we demonstrate that the immediate consequence of blocking the supply of PtdIns(4)P (and therefore PtdIns(4,5)P2) is a failure of agonist-mediated phosphoinositide and Ca2+ signaling. The use of wortmannin also indicated that PtdIns is not a substrate for receptor-activated phospholipase C and that 15% of the basal level of PtdIns(4,5)P2 is in an agonist-insensitive pool. We estimate that the agonist-sensitive pool of PtdIns(4,5)P2 turns over every 5 s (0.23 fmol/cell/min) during sustained receptor activation by a maximally effective concentration of carbachol. Immediately following agonist addition, PtdIns(4,5)P2 is consumed >3 times faster (0.76 fmol/cell/min) than during sustained receptor activation which represents, therefore, utilization by a partially desensitized receptor. These data indicate that resynthesis of PtdIns(4,5)P2 is required to allow full early and sustained phases of receptor signaling. Despite the critical dependence of phosphoinositide and Ca2+ signaling on PtdIns(4,5)P2 resynthesis, we find no evidence that this rate resynthesis is limiting for agonist-mediated responses.

• Authors: G B Willars, S R Nahorski, R A Challiss
• Journal: The Journal of biological chemistry (J Biol Chem) Vol. 273 Issue 9 Pg. 5037-46 (Feb 27 1998) ISSN: 0021-9258 [Print] United States
• PMID: 9478953 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Androstadienes
• Cations, Monovalent
• Chromones
• Enzyme Inhibitors
• Morpholines
• Muscarinic Agonists
• Muscarinic Antagonists
• Phosphatidylinositol 4,5-Diphosphate
• Phosphatidylinositol Phosphates
• Receptor, Muscarinic M3
• Receptors, Muscarinic
• phosphatidylinositol 4-phosphate
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
• Atropine
• Inositol 1,4,5-Trisphosphate
• Carbachol
• Lithium
• Type C Phospholipases
• Wortmannin

Topics

• Androstadienes (pharmacology)
• Atropine (pharmacology)
• Carbachol (pharmacology)
• Cations, Monovalent (pharmacology)
• Chromones (pharmacology)
• Dose-Response Relationship, Drug
• Enzyme Inhibitors (pharmacology)
• Ganglia, Sympathetic (cytology, metabolism)
• Hydrolysis
• Inositol 1,4,5-Trisphosphate (metabolism)
• Lithium (pharmacology)
• Morpholines (pharmacology)
• Muscarinic Agonists (pharmacology)
• Muscarinic Antagonists (pharmacology)
• Neuroblastoma
• Neurons (cytology, metabolism)
• Phosphatidylinositol 4,5-Diphosphate (metabolism)
• Phosphatidylinositol Phosphates (metabolism)
• Receptor, Muscarinic M3
• Receptors, Muscarinic (metabolism)
• Signal Transduction
• Tumor Cells, Cultured
• Type C Phospholipases (metabolism)
• Wortmannin